Earlier this year, we surveyed 1,600 people with Parkinson's and 29 health professionals about using cannabis-derived products. Here are the results.

An update on new legislation on mental capacity and making decisions about a person's health and care, which comes into force from April 2020. 

We’re investing nearly £1 million to find a new treatment that targets energy-producing mitochondria to slow the loss of brain cells in Parkinson's.

In a seminal research paper, published in Lancet Neurology, researchers from King’s College London have used brain scans to uncover early changes in the brain that may happen years before the symptoms of Parkinson's appear.

Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.

New research from Harvard University suggests changes to the gut could improve how a common Parkinson’s medication works.

Researchers in Japan have developed molecules that could be key to slowing the progression of Parkinson’s.

The government has committed to getting 1 million more disabled people into work by 2027. So we want to know what the barriers are for people with Parkinson's to get and stay in employment.

Working closely with local volunteers, Parkinson's UK Cymru has successfully campaigned to save a Parkinson's outpatient clinic on the brink of closure.

Yn gweithio’n agos gyda gwirfoddolwyr lleol, mae Parkinson's UK Cymru wedi ymgyrchu’n llwyddiannus i achub clinig claf allanol Parkinson’s a oedd ar fin cau.

Researchers at King's College London have investigated the properties of over 1,000 approved drugs to identify 2 with potential for Parkinson's.